{"nct_id":"NCT01037348","title":"Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen","status":"COMPLETED","status_verified_date":"2016-04","start_date":"2010-01","start_date_type":null,"primary_completion_date":"2012-05","primary_completion_date_type":"ACTUAL","completion_date":"2012-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}